Ekso Bionics Holdings Statistics
Total Valuation
EKSO has a market cap or net worth of $35.90 million. The enterprise value is $39.93 million.
Important Dates
The next estimated earnings date is Wednesday, March 4, 2026, after market close.
| Earnings Date | Mar 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
EKSO has 3.56 million shares outstanding. The number of shares has increased by 80.51% in one year.
| Current Share Class | 3.56M |
| Shares Outstanding | 3.56M |
| Shares Change (YoY) | +80.51% |
| Shares Change (QoQ) | +22.55% |
| Owned by Insiders (%) | 17.72% |
| Owned by Institutions (%) | 7.31% |
| Float | 2.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.85 |
| Forward PS | 1.57 |
| PB Ratio | 4.03 |
| P/TBV Ratio | 7.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.51.
| Current Ratio | 1.63 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -40.70 |
Financial Efficiency
Return on equity (ROE) is -107.62% and return on invested capital (ROIC) is -48.58%.
| Return on Equity (ROE) | -107.62% |
| Return on Assets (ROA) | -33.62% |
| Return on Invested Capital (ROIC) | -48.58% |
| Return on Capital Employed (ROCE) | -109.59% |
| Weighted Average Cost of Capital (WACC) | 8.41% |
| Revenue Per Employee | $232,709 |
| Profits Per Employee | -$216,745 |
| Employee Count | 55 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 1.27 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.41% in the last 52 weeks. The beta is 0.83, so EKSO's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | +27.41% |
| 50-Day Moving Average | 8.78 |
| 200-Day Moving Average | 5.36 |
| Relative Strength Index (RSI) | 51.85 |
| Average Volume (20 Days) | 144,449 |
Short Selling Information
The latest short interest is 279,360, so 7.84% of the outstanding shares have been sold short.
| Short Interest | 279,360 |
| Short Previous Month | 225,376 |
| Short % of Shares Out | 7.84% |
| Short % of Float | 10.58% |
| Short Ratio (days to cover) | 1.41 |
Income Statement
In the last 12 months, EKSO had revenue of $12.80 million and -$11.92 million in losses. Loss per share was -$4.91.
| Revenue | 12.80M |
| Gross Profit | 6.85M |
| Operating Income | -12.58M |
| Pretax Income | -11.70M |
| Net Income | -11.92M |
| EBITDA | -11.00M |
| EBIT | -12.58M |
| Loss Per Share | -$4.91 |
Full Income StatementBalance Sheet
The company has $1.17 million in cash and $4.64 million in debt, with a net cash position of -$3.48 million or -$0.98 per share.
| Cash & Cash Equivalents | 1.17M |
| Total Debt | 4.64M |
| Net Cash | -3.48M |
| Net Cash Per Share | -$0.98 |
| Equity (Book Value) | 9.03M |
| Book Value Per Share | 2.54 |
| Working Capital | 5.41M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$11.80 million and capital expenditures -$188,000, giving a free cash flow of -$11.99 million.
| Operating Cash Flow | -11.80M |
| Capital Expenditures | -188,000 |
| Free Cash Flow | -11.99M |
| FCF Per Share | -$3.36 |
Full Cash Flow StatementMargins
Gross margin is 53.48%, with operating and profit margins of -98.26% and -91.37%.
| Gross Margin | 53.48% |
| Operating Margin | -98.26% |
| Pretax Margin | -91.37% |
| Profit Margin | -91.37% |
| EBITDA Margin | -85.97% |
| EBIT Margin | -98.26% |
| FCF Margin | n/a |
Dividends & Yields
EKSO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -80.51% |
| Shareholder Yield | -80.51% |
| Earnings Yield | -32.70% |
| FCF Yield | -32.89% |
Analyst Forecast
The average price target for EKSO is $9.50, which is -5.71% lower than the current price. The consensus rating is "Buy".
| Price Target | $9.50 |
| Price Target Difference | -5.71% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 2, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jun 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
EKSO has an Altman Z-Score of -18.73 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -18.73 |
| Piotroski F-Score | 3 |
